IT8621867A0 - Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico. - Google Patents

Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico.

Info

Publication number
IT8621867A0
IT8621867A0 IT8621867A IT2186786A IT8621867A0 IT 8621867 A0 IT8621867 A0 IT 8621867A0 IT 8621867 A IT8621867 A IT 8621867A IT 2186786 A IT2186786 A IT 2186786A IT 8621867 A0 IT8621867 A0 IT 8621867A0
Authority
IT
Italy
Prior art keywords
rein
slow
derivatives
release
galenic formulation
Prior art date
Application number
IT8621867A
Other languages
English (en)
Other versions
IT8621867A1 (it
IT1197316B (it
Inventor
Vanna Springolo
Germano Coppi
Mario Ercole Scevola
Original Assignee
Proter Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proter Spa filed Critical Proter Spa
Priority to IT21867/86A priority Critical patent/IT1197316B/it
Publication of IT8621867A0 publication Critical patent/IT8621867A0/it
Priority to EP87201845A priority patent/EP0264989B1/en
Priority to DE8787201845T priority patent/DE3775335D1/de
Priority to JP62244417A priority patent/JP2572781B2/ja
Priority to US07/102,936 priority patent/US4861599A/en
Publication of IT8621867A1 publication Critical patent/IT8621867A1/it
Application granted granted Critical
Publication of IT1197316B publication Critical patent/IT1197316B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
IT21867/86A 1986-10-01 1986-10-01 Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico IT1197316B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT21867/86A IT1197316B (it) 1986-10-01 1986-10-01 Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
EP87201845A EP0264989B1 (en) 1986-10-01 1987-09-25 Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use
DE8787201845T DE3775335D1 (de) 1986-10-01 1987-09-25 Perorale galenische formulierungen von rheinderivaten mit verzoegerter freigabe.
JP62244417A JP2572781B2 (ja) 1986-10-01 1987-09-30 レイン誘導体の経口用遅延放出性薬剤
US07/102,936 US4861599A (en) 1986-10-01 1987-09-30 Galenic formulations for oral use of rhein derivatives with delayed release for therapeutical use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21867/86A IT1197316B (it) 1986-10-01 1986-10-01 Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico

Publications (3)

Publication Number Publication Date
IT8621867A0 true IT8621867A0 (it) 1986-10-01
IT8621867A1 IT8621867A1 (it) 1988-04-01
IT1197316B IT1197316B (it) 1988-11-30

Family

ID=11187979

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21867/86A IT1197316B (it) 1986-10-01 1986-10-01 Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico

Country Status (5)

Country Link
US (1) US4861599A (it)
EP (1) EP0264989B1 (it)
JP (1) JP2572781B2 (it)
DE (1) DE3775335D1 (it)
IT (1) IT1197316B (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017673A1 (en) * 1992-03-03 1993-09-16 Top Gold Pty., Limited Sustained release analgesics
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
IT1282381B1 (it) * 1996-04-29 1998-03-20 Trans Bussan S A Nuove formulazioni di diacereina, ottenute per inclusione del principio attivo in idrogel polisaccaridi
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
DE19937361A1 (de) * 1999-08-12 2001-02-22 Merck Patent Gmbh Orale Darreichungsform
AR026801A1 (es) * 2000-01-12 2003-02-26 Medidom Lab Sustancias para uso en el tratamiento de la psoriasis
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US8821924B2 (en) 2007-09-14 2014-09-02 Wockhardt Ltd. Rhein or diacerein compositions
US20100285114A1 (en) * 2007-09-27 2010-11-11 Rahul Dabre Pharmaceutical compositions of rhein or diacerein
CA2709236A1 (en) 2007-09-27 2009-04-02 Wockhardt Research Centre Pharmaceutical compositions of rhein or diacerein
WO2009133431A1 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Oral liquid compositions of rhein or diacerein
TWI473610B (zh) * 2008-10-28 2015-02-21 Twi Biotechnology Inc 包含雙醋瑞因（ｄｉａｃｅｒｅｉｎ）之醫藥組合物
MX336355B (es) 2009-03-04 2016-01-14 Orexo Ab Formulacion resistente al abuso.
DK2427177T3 (en) 2009-05-08 2018-06-18 Emplicure Ab Composition for prolonged drug delivery comprising geopolymer binder
NZ608598A (en) 2010-09-07 2015-03-27 Orexo Ab A transdermal drug administration device
CA3018328A1 (en) 2014-10-31 2016-04-30 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
IT1200217B (it) * 1986-09-30 1989-01-05 Valducci Roberto Membrana per uso farmaceutico ed industriale

Also Published As

Publication number Publication date
IT8621867A1 (it) 1988-04-01
JPS63146816A (ja) 1988-06-18
EP0264989A1 (en) 1988-04-27
JP2572781B2 (ja) 1997-01-16
US4861599A (en) 1989-08-29
DE3775335D1 (de) 1992-01-30
IT1197316B (it) 1988-11-30
EP0264989B1 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
IT8621867A0 (it) Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico.
LV5760A4 (lv) Jauns farmaceitisks preparats peroralai lietosanai
DK619987A (da) Galenisk formulering
KR880701541A (ko) 마이크로 캡슐을 포함하는 제약학적 배합물
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO854965L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pteridin-derivater.
IT8423263A0 (it) Formulazioni farmaceutiche acquose di piroxicam monoidrato.
NO871044D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidinderivater.
IT8767057A0 (it) Composizioni farmaceutiche a cessione prolungata relative forme di dosaggio e procedimento per la loro preparazione
ATA327387A (de) Pharmazeutisches ranitidinpraeparat
MX5577A (es) Formulacion farmaceutica
IT8619284A0 (it) Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
NO170085C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (benzofuran-2-yl)imidazoler
IT8621097A1 (it) Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
IT8521214A0 (it) Composizione farmaceutica solida per uso orale.
NO166280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n,n'-disubstituerte ureaer.
IT1197481B (it) Preparazione farmaceutica per uso veterinario
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
DK624587A (da) Farmaceutisk praeparat indeholdende imidazolderivater
IT8520712A0 (it) Formulazioni farmaceutiche per stimolare la liberazione di ormone somatotropo.
DE3768109D1 (de) Pharmazeutische zusammensetzungen.
PH25573A (en) Sulfonylurea derivatives, method of use thereof, pharmaceutical formulation containing said compound

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030